GHRS
GH Research PLC
stockNASDAQ
At CloseOct 2, 2026 3:59:50 PM EDT
22.99USD+0.569%(+0.13)230,107
Loading…
Loading…
1.58B
Healthcare
Biotechnology
HQ
Dublin, Leinster, Ireland
Previous Close
$22.86
Beta
1.45
52-Week High
$31.44 2026-08-07
52-Week Low
$12.04 2025-12-16
SMA 50
$27.73
SMA 200
$20.96
Avg. Vol 10D
362,157
Avg. Vol 30D
240,929
Avg. Vol 90D
280,593
Relative Vol
0.96
68.64M
50.88M
74.12%
2,702,630
5.31%
14.27
43%/57%
37.91%
29.86%
0.6800%
25,000
5
2,122
8,068
Nov 5, 2026 (31d)
GHRS Profile
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
GHRS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 23.42 | 2026-09-28 | -1.75% | 0.052 |
| 1M | 28.23 | 2026-09-04 | -18.49% | 1.028 |
| 3M | 26.17 | 2026-07-06 | -12.07% | 0.775 |
| 6M | 15.14 | 2026-04-06 | +51.98% | 0.585 |
| 1Y | 13.06 | 2025-10-06 | +76.19% | 1.452 |
| 2Y | 6.49 | 2024-10-04 | +254.54% | — |
| 5Y | 21.60 | 2021-10-05 | +6.53% | 1.021 |
GHRS Stock Summary
GH Research PLC (NASDAQ:GHRS) stock price today is $23.01, and today's volume is 230,107. GHRS is up 0.656% today. The 30 day average volume is 240,929. GHRS market cap is $1.58B with 68.64M shares outstanding.